本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Corvus Pharmaceuticals, Inc.

5.43
+0.580011.96%
盤後5.430.0001+0.00%19:49 EDT
成交量:71.88萬
成交額:377.24萬
市值:4.05億
市盈率:-5.34
高:5.49
開:4.96
低:4.92
收:4.85
52周最高:10.00
52周最低:2.54
股本:7,451.40萬
流通股本:6,033.27萬
量比:1.48
換手率:1.19%
股息:- -
股息率:- -
每股收益(TTM):-1.0164
每股收益(LYR):-1.0214
淨資產收益率:-68.67%
總資產收益率:-28.84%
市淨率:5.04
市盈率(LYR):-5.32

資料載入中...

2022/05/05

重要事件披露

8-K - Current report
2022/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/10

重要事件披露

8-K - Current report
2022/03/10

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/18

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/06

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/03

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/02

重要事件披露

8-K - Current report
2021/11/01

重要事件披露

8-K - Current report
2021/11/01

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/22

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/30

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/23

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/22

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals